2 completed, 1 not yet recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 2, Not yet recruiting 1 |
Follow Bendamustine: new trials by email Literature Review of Bendamustine trials Research Report on Bendamustine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BV in the Treatment of Relapsed/refractory Hodgkin Lymphoma Brentuximab Vedotin (Bv), Sintilimab, Tislelizumab - Hodgkin Lymphoma (Category) | Phase 4 | Not yet recruiting | Xiuhua Sun | 100 | 2024-12-31 | 2025-01-07 |
| An Open-Label, Single Arm Study of Obinutuzumab Short Duration Infusion in Patients With Previously Untreated Advanced Follicular Lymphoma Obinutuzumab, Bendamustine, Cyclophosphamide - Advanced Follicular Lymphoma | Phase 4 | Completed | Hoffmann-La Roche | 114 | 2019-02-26 | 2024-04-04 |
| A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe) bendamustine, chlorambucil, rituximab [MabThera/Rituxan] - Lymphocytic Leukemia, Chronic | Phase 4 | Completed | Hoffmann-La Roche | 357 | 2010-03-01 | 2015-06-25 |
Hodgkin Disease (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Recurrence (1)
Hoffmann-La Roche (2) · Xiuhua Sun (1)
Spain (2) · United Kingdom (2) · Brazil (1) · Finland (1) · France (1) · Germany (1) · Japan (1) · Netherlands (1) · Portugal (1) · Sweden (1) · Tunisia (1) · Turkey (Türkiye) (1) · United States (1)
2009 (1), 2018 (1)